
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£183.7b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£117.02
7D
-2.8%
1Y
2.3%
Chugai Pharmaceutical
Market Cap: JP¥11.8t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,184.00
7D
7.4%
1Y
14.9%
Orion Oyj
Market Cap: €11.2b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€77.95
7D
-4.8%
1Y
16.5%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥52.8b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥117.31
7D
5.6%
1Y
30.9%
Xiamen Amoytop Biotech
Market Cap: CN¥24.2b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥59.36
7D
3.1%
1Y
-31.8%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€57.80
7D
-1.4%
1Y
3.3%
PharmaResearch
Market Cap: ₩4.2t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩408,000.00
7D
7.9%
1Y
-38.6%